Ncardia and Cellistic Appoint Charles Jacques as CFO
.png)
Ncardia and Cellistic Appoint Gustavo Mahler to Lead Growth
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Ncardia Secures $60+ Million to Expand iPSC Offerings
Press release: Cell & gene therapy accelerator to de-risk early stage research
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
